BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products.

doi:10.5858/2007-131-1361-BMIMLA

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products.

Archives of pathology & laboratory medicine - 1 Sept 2007

Hay Robert, MacRae Erin, Barber Duane, Khalil Moosa, Demetrick Douglas J

Abstract excerpt

CONTEXT: Mutations of the proto-oncogene B-raf (BRAF) have been detected in melanocytic lesions and papillary carcinomas of the thyroid, and identification of these mutations could be useful in resolving some diagnostic problems. OBJECTIVE: To develop a method to evaluate mutations of BRAF that c...

Topics

Base Sequence
Biopsy, Fine-Needle
Carcinoma, Papillary
DNA, Neoplasm
Humans
Melanoma
Molecular Sequence Data
Mutation
Nevus, Pigmented
Polymerase Chain Reaction
Proto-Oncogene Mas
Proto-Oncogene Proteins B-raf
Skin Neoplasms
Thyroid Neoplasms

Source

Open in PubMed

Identifiers

PMID: 17824790
DOI: 10.5858/2007-131-1361-BMIMLA

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-17824790-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics